Application of EBV (Epstein-Barr virus) BRLF1 and its functional small peptide in inhibiting activity of inflammasomes
An inflammasome and functional technology, applied in the direction of peptides, allergic diseases, peptide/protein components, etc., can solve the problems of unclear activation and regulation mechanisms, achieve good penetration, and inhibit the activity of inflammasomes Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0030] The technical solution of the present invention will be further described below in combination with experiments.
[0031] Unless otherwise specified, the reagents, equipment and methods used in the present invention are commercially available reagents, equipment and routinely used methods in this technical field.
[0032] As a gamma-herpes virus, EBV has a life cycle that is divided into a latent period and a lytic period. After a short acute response, the cells enter the latent period quickly after being infected. In the host cell, the EBV viral genome can continuously activate the host's inflammasome system, enabling cells to maintain a certain level of inflammasome activation. As another type of human herpes virus, HSV-1 mainly performs infection and replication during the lytic phase, and can rapidly activate a series of inflammasome systems through its viral genome and viral proteins after infecting cells. Therefore, detection of inflammasome activity activated by...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com